Report Title | Price | Action |
---|---|---|
Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Development, 2021
Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Development, 2021 Summary Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
Liposarcoma (Oncology) - Drugs in Development, 2021
Liposarcoma (Oncology) - Drugs in Development, 2021 Summary Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Liposarc...
Published: Apr-2021 | No. of Pages: 80
|
$ 2000 | |
Paralysis (Central Nervous System) - Drugs in Development, 2021
Paralysis (Central Nervous System) - Drugs in Development, 2021 Summary Paralysis (Central Nervous System) - Drugs in Development, 2021 provides an ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Burkitt Lymphoma (Oncology) - Drugs in Development, 2021
Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 Summary Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of th...
Published: Apr-2021 | No. of Pages: 110
|
$ 2000 | |
Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform or Endoplasmic Reticulum Class 1/2 Ca(2+) ATPase or SERCA2 or ATP2A2 or EC 7.2.2.10) - Drugs in Development, 2021
Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Mu...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) - Drugs in Development, 2021
Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) - Drugs in Development, 2021 Summary Compl...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 (Membrane Component Chromosome 6 Surface Marker 1 or Phosphodiesterase I/Nucleotide Pyrophosphatase 1 or Plasma Cell Membrane Glycoprotein PC1 or ENPP1 or EC 3.1.4.1 or EC 3.6.1.9) - Drugs in Development, 2021
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 (Membrane Component Chromosome 6 Surface Marker 1 or Phosphodiesterase I/Nucleotide P...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
Norovirus Infections (Infectious Disease) - Drugs in Development, 2021
Norovirus Infections (Infectious Disease) - Drugs in Development, 2021 Summary Norovirus Infections (Infectious Disease) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021
Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Simplexvirus (HSV) Infections (Infectious Disease) - Drugs i...
Published: Apr-2021 | No. of Pages: 70
|
$ 2000 | |
Partial Seizure (Central Nervous System) - Drugs in Development, 2021
Partial Seizure (Central Nervous System) - Drugs in Development, 2021 Summary Partial Seizure (Central Nervous System) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
Cachexia (Musculoskeletal) - Drugs in Development, 2021
Cachexia (Musculoskeletal) - Drugs in Development, 2021 Summary Cachexia (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
Sclerostin (SOST) - Drugs in Development, 2021
Sclerostin (SOST) - Drugs in Development, 2021 Summary Sclerostin (SOST) - Drugs in Development, 2021 provides in depth analysis on Sclerostin (SOST...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021
CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021 Summary CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
Egl Nine Homolog 1 (Hypoxia Inducible Factor Prolyl Hydroxylase 2 or Prolyl Hydroxylase Domain Containing Protein 2 or SM 20 or EGLN1 or EC 1.14.11.29) - Drugs in Development, 2021
Egl Nine Homolog 1 (Hypoxia Inducible Factor Prolyl Hydroxylase 2 or Prolyl Hydroxylase Domain Containing Protein 2 or SM 20 or EGLN1 or EC 1.14.11.29...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021
Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021 Summary Diabetic Complications (Metabolic Disorders) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
Streptococcal Infections (Infectious Disease) - Drugs in Development, 2021
Streptococcal Infections (Infectious Disease) - Drugs in Development, 2021 Summary Streptococcal Infections (Infectious Disease) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
Pemphigus (Immunology) - Drugs in Development, 2021
Pemphigus (Immunology) - Drugs in Development, 2021 Summary Pemphigus (Immunology) - Drugs in Development, 2021 provides an overview of the Pemphigu...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021
Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 Summary Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte/Brain or GLUT1 or HepG2 Glucose Transporter or SLC2A1) - Drugs in Development, 2021
Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte/Brain or GLUT1 or HepG2 Glucose Transporter o...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) - Drugs in Development, 2021
Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) - Drugs in Development, 2021 Summary Histamine H3 Receptor (G Protein Couple...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 |